Printer Friendly
The Free Library
19,588,385 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

An Overview of the Clinical Molecular Diagnostic Tests Currently Being Used and the New Developments That Are Expected in the Industry.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c1455) has announced the addition of Molecular Diagnostics Markets to their offering. E[acute accent]The purpose of this report is to survey the specific market segment of the in vitro diagnostics In vitro diagnostic (IVD) tests are medical tests conducted in a test tube, or more generally in a controlled environment outside a living organism. In vitro means in glass in Latin.  market called molecular diagnostics. This report includes all of the generally accepted clinical molecular diagnostic tests that are currently used today, and explores new tests that are on the clinical horizon. It examines the clinical measurement devices and their reagents and supplies as utilized in hospital and commercial labs, clinics, and doctors' offices, including exciting new developments in probe based nucleic acid nucleic acid, any of a group of organic substances found in the chromosomes of living cells and viruses that play a central role in the storage and replication of hereditary information and in the expression of this information through protein synthesis.  assays, microarrays, sequencing and DNA chips (lab on a chip) for disease detection. E[acute accent]This report reviews the market for clinical molecular diagnostics testing equipment and supplies in the clinical hospital market, using screening reagents and instruments for analysis of individual components in blood, serum or plasma. It defines the dollar volume of sales, both worldwide and in the U.S. of the market and analyzes the factors that influence the size and the growth of the market segments. The report details market sizes and growth rates Growth Rates

The compounded annualized rate of growth of a company's revenues, earnings, dividends, or other figures.

Notes:
Remember, historically high growth rates don't always mean a high rate of growth looking into the future.
, with projections usually through the year 2009 or beyond, if that makes sense, for the U.S. and world market. E[acute accent]The report surveys virtually all of the over 200 companies known to be marketing, manufacturing or developing instruments and reagents for the molecular diagnostics market in the U.S and worldwide. Leading companies are discussed in depth with a section on the history of the company, the product line, business and marketing analysis, and a subjective commentary of the position of the company in its market.

Topics Covered 1. Overview 2. Introduction to Molecular Diagnostics and PCR PCR polymerase chain reaction.

PCR
abbr.
polymerase chain reaction


Polymerase chain reaction (PCR) 
 Technology 3. Nucleic Acid Test (NAT (Network Address Translation) An IETF standard that allows an organization to present itself to the Internet with far fewer IP addresses than there are nodes on its internal network. ) Applications 4. Trends in Molecular Diagnostics 5. New Products Under Development 6. Market Trends and Forecasts 7. Corporate Directory 8. Market Overview List of Tables List of Figures

Summary The principal objectives of this report are to: 1. identify viable technology drivers through a comprehensive look at various platform technologies for molecular diagnostics, including immunoassays, probe-based nucleic acid assays, microarrays, and sequencing, 2. obtain a complete understanding of the chief molecular diagnostic tests-predictive, screening, prognostic, monitoring, pharmacogenomic, and theranostic-from their basic principles to their applications, 3. discover feasible market opportunities via an identification of high-growth applications in different therapeutic areas, with a focus on the biggest and expanding markets-communicable diseases, cardiology, and oncology, and 4. focus on global industry development through an in-depth analysis of the major world markets for molecular diagnostics, including forecasts for growth.

E[acute accent]Companies Mentioned

E[acute accent]--Abbott Laboratories - Aclara BioSciences - Affymetrix - Agilent - Ambion - Amersham Pharmacia Biotech - Applera Applied Biosystems - Bayer Corporation - Beckman Coulter Inc. - BioMerieux - Bio-Rad Laboratories - Biotest AG - Caliper caliper

Instrument that consists of two adjustable legs or jaws for measuring the dimensions of material parts. Spring calipers have an adjusting screw and nut; firm-joint calipers use friction at the joint to hold the legs unmoving.
 Technologies - Cellomics - Cepheid - Chiron - Ciphergen Biosystems - Curagen Corporation - Cytocell - DakoCytomation A/S - DiaDexus - Digene Diagnostics Inc - Enzo Diagnostics - Epigenomics - Epoch Biosciences - EraGen Bioscience - Eurogentec - Exiqon - Gene Link Inc. - Gene Logic - Genometrix - Genisphere - Gen-Probe - Genset - Genzyme - ID Biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 - Hamilton Thorne Biosciences - Hyseq Inc. (Nuvelo) - ID Biomedical - IGEN International - Illumina - Incyte Genomics Inc. - Incyte Pharmaceuticals - Infectio Diagnostic Inc - Innogenetics NV/SA - InnoGenex - Interleukin Genetics - Invitrogen - Kreatech Diagnostics - LabCorp - LI-COR - Matritech - Meridian Biosciences - Millennium Predictive Medicine - MitoKor - Motorola - MWG MWG Men with Guts (sports apparel company)
MWG Match-Winning Goal (soccer)
mWG Microworld of Gems (e-commerce business)
MWG Measurements Working Group
MWG Model Working Group
 Biotech - Myriad Genetics - Nanogen - Nanosys - Nimblegen Inc. - Nova Molecular Inc. - Nymox Pharmaceutical - Orchid Biocomputer - Orchid Cellmark - OrganonTeknika - Ortho-Clinical Diagnostics - Ostex - PE Tropix - PerSeptive Biosystems - PharMingen - PNA PNA Palestinian National Authority
PNA Phoneline Networking Alliance
PNA Peptide Nucleic Acid
PNA Personal Navigation Assistant
PNA Pacific/North American
PNA Polish National Alliance (established 1880 in Chicago, Illinois) 
 Diagnostics - PPD (1) (Parallel Presence Detect) The method used by earlier SIMM memory modules to communicate their capacity to the computer. A binary number coming from a parallel set of pins was read by the system, with each pin representing one bit. Contrast with SPD.  - PPGx - Prodesse Inc. - Professional Genetics Laboratory (PGL Persistent generalized lymphadenopathy (PGL)
A condition in which HIV continues to produce chronic painless swellings in the lymph nodes during the latency period.

Mentioned in: AIDS
) - Promega - Pyrosequencing - Orchid BioSciences Inc. - Qiagen - Quantum Biotechnologies - Quidel - Response Biomedical Corp. - Roche Molecular Systems - Sequenom - SurModics - Tepnel Life Sciences - Thermo Electron - Third Wave Technologies - TIB See NIST binary.  Molbiol - Fluoreszenz - TM Bioscience - Variagenics - Visible Genetics - Vysis - VisiGen Biotechnologies Inc. - Callida Genomics - Mobious Genomics - Perlegen - Solexa - U.S. Genomics - Visigen

E[acute accent]For more information visit http://www.researchandmarkets.com/reports/c1455
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 5, 2006
Words:638
Previous Article:Datacolor's ColorVision Business Unit Terminates Co-Marketing Agreement with PANTONE; Commitment to Digital Color Management Strengthened by Direct...
Next Article:EVE Offers Catalog of High-Performance Peripheral IP to Address Wireless, Graphics/Video/Multimedia, Networking, Processor Markets; Memory,...
Topics:



Related Articles
DXS AND SANGTEC SIGN SCORPIONS TECHNOLOGY LICENSE PACT.
ABBOTT/EUROPROTEOME TO DEVELOP BREAST CANCER DIAGNOSTIC TESTS.
Research and Markets: Molecular Diagnostics Markets.
Research and Markets: Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and Development.
Rising Demand for Effective Prognosis Spurs the Uptake of Molecular Diagnostics.
New Discoveries and Innovative Technologies Create Growth Opportunities in the IVD Market.
Web Alert: Xenomics' Breakthrough DNA Technology to be Presented Today at Bio InvestorForum with Online Simulcast; CEO to Detail Revolutionary DNA...
New FDA Initiatives to Accelerate the Approval of Emerging Diagnostics and Drugs.
The Molecular Diagnostics 2007 Market: Technologies, Companies, Products, Applications and Worldwide Outlook.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles